Healthy Living/WellnessFDA approves hay fever drug Oralair: Goodbye sneezing and allergy shots. French company Stallergenes' Oralair will soon be available in the U.S. providing new option to patients with hay fever.by Rhodi Lee
ScienceWant to lose weight? Take a walk in the sunlight, but do it in the morning, scientists sayby Jim Algar
Healthy Living/WellnessKetamine for depression? Horse tranquilizer, party drug under study as medicine for humansby Rhodi Lee
Healthy Living/WellnessFDA advisers give thumbs up to MannKind's inhaled insulin drug for diabeticsby Maryanne Moll
Healthy Living/WellnessApple slices or fries? 'Deceptive' fast food advertising confuses childrenby Tabitha Laffernis
Healthy Living/WellnessImmunotherapy makes its way to the U.S. in the form of grass allergy pill Oralairby Tabitha Laffernis
Healthy Living/WellnessWHO says Ebola outbreak in Guinea relatively small. What's to know about the deadly virus?by Rhodi Lee
Healthy Living/WellnessIs Novartis' LCZ696 the next gold standard of heart failure drugs?by Rhodi Lee
Healthy Living/WellnessBenefits of Vitamin D supplements are just part of marketing hype and big myth?by Rhodi Lee
Healthy Living/WellnessDementia diagnosis push in Britain may lead to overdiagnosis: Studyby Maryanne Moll
Healthy Living/WellnessBariatric surgery helps control symptoms of Type 2 diabetes in overweight, obese patientsby Rhodi Lee